MedTrace Logo

TRACE: Tirapazamine-Radiation And Cisplatin Evaluation

NCT00174837 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 317

Last updated 2016-05-26

No results posted yet for this study

Summary

The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.

Conditions

Interventions

DRUG

Tirapazamine

in combination with cisplatin and concomitant radiation

DRUG

Cisplatin

with concomitant radiation

Sponsors & Collaborators

  • Groupe Oncologie Radiotherapie Tete et Cou

    collaborator OTHER

  • Sanofi

    lead INDUSTRY

Principal Investigators

  • ICD CSD · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States
  • Argentina
  • Australia
  • Canada
  • Chile
  • France
  • Germany
  • Hong Kong
  • Hungary
  • Italy
  • New Zealand
  • Poland
  • Singapore
  • South Africa
  • Spain
  • Switzerland
  • Taiwan

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00174837 on ClinicalTrials.gov